Robert J. Hariri
CIK: 0001398815
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 5, 2026CYRX
Cryoport, Inc.
Award(A)Direct10.4K shares- - Apr 13, 2026CELU
Celularity Inc
Exercise(M)Direct3.3K shares- - Apr 13, 2026CELU
Celularity Inc
Tax Payment(F)Direct1.2K shares at avg. $1.28$2K - Sep 11, 2025CYRX
Cryoport, Inc.
Exercise(M)Direct50K shares at avg. $2.66$133K - Sep 11, 2025CYRX
Cryoport, Inc.
Sale(S)Direct25K shares at avg. $9.71$243K - Aug 22, 2025CYRX
Cryoport, Inc.
Sale(S)Direct5K shares at avg. $8.60$43K - Jun 6, 2025CYRX
Cryoport, Inc.
Award(A)Direct23.2K shares- - May 28, 2025CYRX
Cryoport, Inc.
Sale(S)Direct12.5K shares at avg. $6.10$76K - Apr 13, 2025CELU
Celularity Inc
Exercise(M)Direct3.3K shares- - Apr 13, 2025CELU
Celularity Inc
Tax Payment(F)Direct1.2K shares at avg. $1.64$2K - Dec 20, 2024BIVI
BIOVIE INC.
Award(A)DirectStock Option (right to buy)
21.8K shares- - Nov 21, 2024CYRX
Cryoport, Inc.
Sale(S)Direct2.5K shares at avg. $6.48$16K - Nov 20, 2024BIVI
BIOVIE INC.
Award(A)DirectStock Option (right to buy)
49.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  CYRX Cryoport, Inc. | Award(A) | 10,350 | - | $0 | Direct |
| Apr 13, 2026 |  CELU Celularity Inc | Exercise(M) | 3,281 | - | $0 | Direct |
| Apr 13, 2026 | CELU Celularity Inc | Tax Payment(F) | 1,182 | $1.28 | $1,513 | Direct |
| Sep 11, 2025 | CYRX Cryoport, Inc. | Exercise(M) | 50,000 | $2.66 | $133,000 | Direct |
| Sep 11, 2025 | CYRX Cryoport, Inc. | Sale(S) | 25,000 | $9.71 | $242,738 | Direct |
| Aug 22, 2025 | CYRX Cryoport, Inc. | Sale(S) | 5,000 | $8.60 | $43,000 | Direct |
| Jun 6, 2025 | CYRX Cryoport, Inc. | Award(A) | 23,214 | - | - | Direct |
| May 28, 2025 | CYRX Cryoport, Inc. | Sale(S) | 12,500 | $6.10 | $76,250 | Direct |
| Apr 13, 2025 | CELU Celularity Inc | Exercise(M) | 3,281 | - | - | Direct |
| Apr 13, 2025 | CELU Celularity Inc | Tax Payment(F) | 1,154 | $1.64 | $1,893 | Direct |
| Dec 20, 2024 |  BIVI BIOVIE INC. | Award(A) Stock Option (right to buy) | 21,815 | - | - | Direct |
| Nov 21, 2024 | CYRX Cryoport, Inc. | Sale(S) | 2,500 | $6.48 | $16,200 | Direct |
| Nov 20, 2024 | BIVI BIOVIE INC. | Award(A) Stock Option (right to buy) | 49,800 | - | - | Direct |
1-13 of 13 transactions
About Hariri Robert J
Hariri Robert J (SEC CIK 0001398815) files insider reports with the SEC as Director of Cryoport, Inc. (CYRX), Chief Executive Officer of Celularity Inc (CELU) and Director of BIOVIE INC. (BIVI).
Signal8 holds 10 ownership filings by Hariri Robert J, all Form 4s, filed between Dec 2, 2024 and Jun 8, 2026. Those filings report 13 transactions, from Nov 20, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hariri Robert J's filings is in BRENTWOOD, TN.
Recent filings by Hariri Robert J
- Jun 5, 2026: Grant or award of CYRX shares (Form 4, code A).
- Apr 13, 2026: Option exercise of CELU shares (Form 4, code M).
- Apr 13, 2026: Tax withholding of CELU shares (Form 4, code F).
- Sep 11, 2025: Option exercise of CYRX shares (Form 4, code M).
- Sep 11, 2025: Open-market sale of CYRX shares (Form 4, code S).
Other insiders filing for Cryoport, Inc. (CYRX)
- SHELTON JERRELL, President, CEO
- ZECCHINI EDWARD J, Chief Digital and Tech Officer
- BADDOUR LINDA, Director
- STEFANOVICH ROBERT, Chief Financial Officer
- HANCOCK DANIEL M, Director
- Mandalam Ramkumar, Director